SPARK Neuro
SPARK Neuro is a company focused on making brain health measurement universal and accessible, utilizing their FDA-cleared SPARK Scan device for dementia screening.
Company Overview
SPARK Neuro is a healthcare technology company headquartered at 2450 Colorado Avenue, Suite 100E, Santa Monica, California, 90404. The company focuses on making brain health measurement universal and accessible. With the mission to make brain health care as routine as measuring blood pressure, SPARK Neuro has received over $35 million in funding and collected over 900 datasets since 2021.
SPARK Neuro Clinical Trials
As of 2023, SPARK Neuro has conducted four clinical trials aimed at advancing dementia screening and diagnosis. These trials are part of the company's commitment to improving brain health and reducing undiagnosed dementia cases, which currently account for nearly half of all instances.
SPARK Scan
The SPARK Scan is an FDA-cleared, Class-II device designed for dementia screening. It utilizes A.I. algorithms to analyze EEG data and is accessible for use both at home and in clinics. The SPARK Scan boasts a disease classification accuracy of over 90% and maintains a low false positive rate of 1:4. Early diagnosis through this device could save up to $7.9 trillion annually.
FDA Clearances
SPARK Neuro has received two FDA clearances as of 2024. These clearances validate the efficacy and safety of their SPARK Scan device, which is used for analyzing EEG data to screen for dementia.
Funding and Data Collection
Since its inception, SPARK Neuro has attracted over $35 million in funding. The company has also been active in data collection, amassing over 900 datasets since 2021. These efforts support SPARK Neuro's aim to make brain health assessment a routine part of healthcare.